The standard dose varies widely from 300,000 IU as a single injection for severe deficiency to smaller, more frequent doses
Get Moving Incorporate light to moderate physical activity, such as walking, strength training, or yoga, to boost metabolism and preserve muscle
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Molecular Formula : CHN Molecular Weight : 159.21 g/mol PubChem CID : 950107 CAS Number : 42464-96-0 Synonyms : 5-amino-1-methylquinolinium Source: PubChem In controlled laboratory settings, 5-Amino-1MQ may be used to investigate how NNMT modulation affects NAD+ availability, redox balance, and related metabolic pathways
Standard AOD-9604 Dosing Protocol Typical Dosing Range: Standard Dose: 250-500 mcg per day Clinical Trial Dose: 1 mg (1,000 mcg) per day (most effective in studies) Conservative Start: 250 mcg per day for first week Maintenance Range: 500 mcg per day for sustained protocols Frequency: Once daily, typically before breakfast Timing Rationale: Morning fasted state maximizes fat oxidation potential Cycle Length: 12-24 weeks for body composition protocols Administration Route: Subcutaneous injection (abdomen, thigh, or upper arm) Reconstitution: Bacteriostatic water, standard peptide protocols Note: Clinical trials used oral formulations, but subcutaneous administration is more common in current use due to improved bioavailability
Monthly injections are well suited to maintenance, keeping already-healthy levels healthy, but they are often not enough during the correction phase for someone who is significantly deficient
.webp)